Radiation Dose from Whole-Body F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Nationwide Survey in Korea
暂无分享,去创建一个
J. S. Lee | Hyun Woo Kwon | G. Cheon | D. Lee | K. Kang | J. Paeng | June-Key Chung | Jong Phil Kim | H. Lee | J. Lee
[1] S. Vogiatzi,et al. Collective effective dose in Europe from X-ray and nuclear medicine procedures. , 2015, Radiation protection dosimetry.
[2] S. Vogiatzi,et al. Analysis of factors correlating with medical radiological examination frequencies. , 2015, Radiation protection dosimetry.
[3] E. Petrova,et al. Patient doses from PET-CT procedures. , 2015, Radiation protection dosimetry.
[4] Paul Kinahan,et al. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials , 2015, The Journal of Nuclear Medicine.
[5] Eric J. W. Visser,et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[6] H Bergmann,et al. Variation of system performance, quality control standards and adherence to international FDG-PET/CT imaging guidelines , 2014, Nuklearmedizin.
[7] P. Roch,et al. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011. , 2012, Radiation protection dosimetry.
[8] Koichiro Abe,et al. Improvement in PET/CT Image Quality with a Combination of Point-Spread Function and Time-of-Flight in Relation to Reconstruction Parameters , 2012, The Journal of Nuclear Medicine.
[9] Donald L. Miller,et al. Cancer risks associated with external radiation from diagnostic imaging procedures , 2012, Ca.
[10] D. Lee,et al. The Current Status and Future Perspectives of Nuclear Medicine in Korea , 2010, Nuclear medicine and molecular imaging.
[11] R. Bly,et al. Recently revised diagnostic reference levels in nuclear medicine in Bulgaria and in Finland. , 2010, Radiation protection dosimetry.
[12] R. Smart,et al. Diagnostic Reference Activities for Nuclear Medicine Procedures in Australia and New Zealand Derived from the 2008 Survey , 2009 .
[13] W. Oyen,et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[14] Ronald Boellaard,et al. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[15] Suleman Surti,et al. Benefit of Time-of-Flight in PET: Experimental and Clinical Results , 2008, Journal of Nuclear Medicine.
[16] Icrp. Main Text , 2008, Annals of the ICRP.
[17] H. Nagel,et al. CT-Expo - ein neuartiges Programm zur Dosisevaluierung in der CT , 2002 .
[18] J. Valentin,et al. Radiation dose to patients from radiopharmaceuticals: (Addendum 2 to ICRP Publication 53) ICRP Publication 80 Approved by the Commission in September 1997 , 1998, Annals of the ICRP.
[19] D. Mieth,et al. Ethical Aspects of Cloning Techniques , 1997, Politics and the Life Sciences.
[20] 伊沢 正実,et al. Recommendations of the International Commission on Radiological Protection , 1961 .
[21] G. Stamm,et al. [CT-expo--a novel program for dose evaluation in CT]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[22] International Commission on Radiological Protection, Committee I. The evaluation of risks from radiation. , 1966, Health physics.